Old Web
English
Sign In
Acemap
>
authorDetail
>
Wan-Ju Lee
Wan-Ju Lee
AbbVie
Disease
Diabetes mellitus
Medicine
Internal medicine
Crohn's disease
3
Papers
33
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study.
2021
Journal of Crohns & Colitis
Marc Ferrante
Brian G. Feagan
Julián Panés
Filip Baert
Edouard Louis
Olivier Dewit
Arthur Kaser
W Rachel Duan
Yinuo Pang
Wan-Ju Lee
Dawn Gustafson
Xiaomei Liao
Kori Wallace
Jasmina Kalabic
Geert R. DHaens
Show All
Source
Cite
Save
Citations (3)
Systematic review and meta-analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn's disease.
2020
Alimentary Pharmacology & Therapeutics
Ryan C. Ungaro
Saurabh Aggarwal
Ozlem Topaloglu
Wan-Ju Lee
Ryan Clark
Jean-Frederic Colombel
Show All
Source
Cite
Save
Citations (18)
Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
2019
Gut
Remo Panaccione
Jean-Frederic Colombel
Simon Travis
Peter Bossuyt
Filip Baert
Tomáš Vaňásek
Ahmet Danalioglu
Gottfried Novacek
Alessandro Armuzzi
Walter Reinisch
Scott J. Johnson
Marric Buessing
Ezequiel Neimark
J Petersson
Wan-Ju Lee
Geert R D’Haens
Show All
Source
Cite
Save
Citations (12)
1